Associated Papers
A novel pathogenic variant in LCAT causing FLD. A case report.
Goñi Ros N et al.
Acta Clinica Belgica, 2022
A systematic review of the natural history and biomarkers of primary lecithin:cholesterol acyltransferase deficiency.
Vitali C et al.
Journal of Lipid Research, 2022
35065092 (PubMed )
Supplement: mmc1.pdf
LCAT deficiency: a systematic review with the clinical and genetic description of Mexican kindred.
Mehta R et al.
Lipids in Health and Disease, 2021
Identification and functional analysis of missense mutations in the lecithin cholesterol acyltransferase gene in a Chilean patient with hypoalphalipoproteinemia.
Tobar HE et al.
Lipids in Health and Disease, 2019
Polygenic determinants in extremes of high-density lipoprotein cholesterol.
Dron JS et al.
Journal of Lipid Research, 2017
28870971 (PubMed )
Supplement: 10.1194_M079822_jlr.M079822-1.pdf
Lipoprotein subfractions highly associated with renal damage in familial lecithin:cholesterol acyltransferase deficiency.
Kuroda M et al.
Arteriosclerosis, Thrombosis, and Vascular Biology, 2014
Lipid oxidation in carriers of lecithin:cholesterol acyltransferase gene mutations.
Holleboom AG et al.
Arteriosclerosis, Thrombosis, and Vascular Biology, 2012
Patients with low HDL-cholesterol caused by mutations in LCAT have increased arterial stiffness.
van den Bogaard B et al.
Atherosclerosis, 2012
Reconstituted high-density lipoprotein shortens cardiac repolarization.
Den Ruijter HM et al.
Journal of the American College of Cardiology, 2011
Characterization of antioxidant/anti-inflammatory properties and apoA-I-containing subpopulations of HDL from family subjects with monogenic low HDL disorders.
Daniil G et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry, 2011
Select a paper to view details